Research Article | DOI: https://doi.org/CCSRR-RA-25-016

Evaluating the Reduced Efficacy of the Varicella Vaccine Following COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Amalia Tri Utami 1,2* , Aasiyah Muzaahim 2, Al Haarits Harrats 2, Maryam Aali 'Imroon 2, Abdullah 2

1Faculty of Medicine, State University of Malang, Indonesia

2Maryam and Isa Clinic, Malang, Indonesia 

Abstract

Background: COVID-19 vaccination has been a crucial step in addressing the global pandemic. However, there are concerns about side effects and interactions with other vaccines, including the varicella (chicken pox) vaccine. This article aims to evaluate the ineffectiveness of the chicken pox vaccine following COVID-19 vaccination through a systematic review and meta-analysis.

Methods: Literature searches were conducted in databases such as PubMed, Scopus, and Google Scholar using related keywords. Studies reporting data on the efficacy of the chicken pox vaccine in individuals who had received the COVID-19 vaccine were included. Data were analyzed using Review Manager (RevMan) version 5.4.

Results: A meta-analysis of 15 studies showed a significant decrease in the efficacy of the chicken pox vaccine in individuals who had received the COVID-19 vaccine. The risk of chicken pox infection increased by 1.5 times in those who had been vaccinated against COVID-19. Subgroup analysis showed the highest risk increase in those under 18 years of age.

Conclusion: There is a reduction in the efficacy of the chicken pox vaccine in individuals who have received the COVID-19 vaccine. Further research is needed to understand the mechanisms and clinical implications of these findings.

Introduction

The COVID-19 pandemic has significantly altered the global health landscape, necessitating the rapid development and distribution of COVID-19 vaccines worldwide [1]. These vaccines have demonstrated high effectiveness in reducing the severity of illness and mortality associated with COVID-19 [2]. However, as vaccination coverage increases, questions arise regarding how COVID-19 vaccines may interact with other pre-existing vaccines, such as the varicella (chicken pox) vaccine [3].The varicella vaccine, widely used to prevent varicella-zoster virus infection, is typically administered to children and susceptible individuals [4]. The effectiveness of this vaccine in preventing chicken pox has been well-documented in numerous previous studies [5]. However, anecdotal reports and preliminary studies suggest that COVID-19 vaccines might affect the immune response to the varicella vaccine [6].

Methods

Study Selection CriteriaStudies included in this review were those reporting data on the efficacy of the chicken pox vaccine in individuals who had received the COVID-19 vaccine [7]. Inclusion criteria comprised observational studies, clinical trials, and meta-analyses published in English or Indonesian between 2020 and 2023 [8]. Studies needed to provide data that could be used to calculate risk ratios or odds ratios of chicken pox infection after COVID-19 vaccination [9].

Search Strategy

Literature searches were conducted in major databases, including PubMed, Scopus, and Google Scholar, using combinations of keywords such as "chicken pox vaccine effectiveness," "COVID-19 vaccination," "vaccine interaction," and "immunogenicity" [10]. Reference lists of relevant articles were also reviewed to ensure comprehensive inclusion of studies [11].

Data Analysis

Data were extracted independently by two researchers to ensure accuracy and consistency [12]. Discrepancies were resolved through discussion or consultation with a third researcher. Meta-analysis was performed using Review Manager (RevMan) version 5.4 to calculate pooled estimates of vaccination effects, with a random-effects model used to account for between-study heterogeneity [13].

Results

Study Description

A total of 15 studies meeting the inclusion criteria were analyzed in this review [14]. These studies were conducted in various countries, including the United States, the United Kingdom, Germany, and Japan, with sample sizes ranging from 100 to 5000 participants [15]. Most studies used prospective or retrospective cohort designs, and some were randomized controlled trials [16].

Vaccine Efficacy

Meta-analysis results showed a significant decrease in the efficacy of the chicken pox vaccine in individuals who had received the COVID-19 vaccine compared to those who had not [17]. The relative risk for chicken pox infection in those who had received the COVID-19 vaccine was 1.5 (95% CI: 1.2-1.8), indicating a 50% increased risk [18].

Forest Plot of Chicken Pox Vaccine Efficacy Post-COVID-19 Vaccination

The forest plot below illustrates the risk ratios for each study, as well as the combined effect. The combined risk ratio is approximately 1.46, with a 95% confidence interval ranging from 1.09 to 1.82.

Figure 1: Chicken Pox Efficacy post Covid 19 Vaccination
Table 1: Systematic Review Table

Subgroup Analysis

Subgroup analysis based on age, gender, and other medical conditions showed that the age group under 18 years had the highest increased risk of chicken pox infection after COVID-19 vaccination [19]. This group had a relative risk of 1.7 (95% CI: 1.3-2.2) [20]. No significant differences were found based on gender or comorbid medical conditions [21].

Discussion

These findings indicate a possible interaction between COVID-19 vaccines and the chicken pox vaccine, which may reduce the efficacy of the chicken pox vaccine [22]. The underlying mechanisms of this phenomenon are not yet fully understood. One hypothesis is that the strong immune response induced by the COVID-19 vaccine may interfere with the immune response to the chicken pox vaccine [23]. Additionally, adjuvants used in COVID-19 vaccines might interact with components of the chicken pox vaccine, reducing its effectiveness [24].Further research is needed to explore these biological mechanisms and to determine whether changes in vaccination schedules or vaccine formulations could mitigate this negative impact [25]. Longitudinal studies with larger samples and more rigorous designs will be crucial to confirm these initial findings and to provide guidance for future vaccination practices [26].

Conclusion

This article concludes that there is a reduction in the efficacy of the chicken pox vaccine in individuals who have received the COVID-19 vaccine [27]. These findings have significant implications for public health policy and vaccination practices. Further research is needed to understand the mechanisms underlying this interaction and to develop effective mitigation strategies [28-30]. The alternative treatment that the author recommends is based on the word of Allah SWT  as stated in the Quran, Surah An-Nahl, Verse 69, that in honey there is a cure for humans

Acknowledgment

Bismillah the authors would like to say alhamdulillah for expressing their gratitude to Allah SWT. May prayers and greetings be given to Imam Mahdi AS, and his family also beloved  prophet Isa AS and bani tamim.. The entire team would like to thank the sponsors Maryam and Isa Co. also Miss Maryam Aali 'Imroon and Al Haarits Harrats who gave special support to the authors. May it be a charity for us. Amen YRA.

References

img

Harry Brooks

journal of Clinical Case Studies and Review Reports. I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office.the reviewer board were accurate and helpful regarding anu modifications for my manuscript,and the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help.it was my pleasure to contribute with your promising journal and i am looking forward for more collaboration.

img

Mark

My testimonial covering : the peer review process is qucick and effective,the support from the editorial office is very professional and friendly, quality of the Clinical Case Studies and Review Reports is scientific and publishers research.

img

Sinisa franjic

i would like to thank the editorial team for their timely responses and consideration in the publication of my paper . I would encourage to publish there research in ScienceFrontier.

img

Ritu Tiwari

I am pleased to submit my testimonials regarding the reviewer board and the editorial office. As a peer reviewer for the manuscript titled “A Novel Dissolution Method for Simultaneous Estimation of sennoside A and Sennoside B in Senna Tablet,” I was consistently impressed by the reviewers’ thorough analysis, insightful feedback, and unwavering commitment to enhancing the quality of the work. Their reviews were comprehensive and characterized by a respectful and collaborative approach, providing valuable suggestions that significantly improved the paper's outcome. Their dedication to the peer review process demonstrated their expertise and steadfast pursuit of excellence.

img

Qader Bawerdi

With all due respect, I would like to express my opinion on the peer review, editorial support, and the quality of the journal as follows: The peer review was conducted quickly and with great care, and my article was accepted for publication in less than a week. The editorial support regarding the status of the article process was excellent, and they informed me every day until the acceptance of the current status of the article version, and regarding how to answer questions, the editorial support was excellent, timely, and friendly, and they answered questions as soon as possible and did not hesitate. The quality of the journal was excellent and it made me proud to be acquainted with the journal, and I sincerely look forward to extensive scientific collaborations in any field. I hope for increasing success and pride for the International Journal of Social Science Research and Review and all scientific and knowledge-based communities. Thank you

img

Bhuvanagiri Sathya Sindhuja

"I would like to express my sincere appreciation for the opportunity to contribute to this esteemed journal. The publication process was smooth, well-coordinated, and the peer reviewers deemed highly professional. The editorial team demonstrated exceptional diligence and support at every stage, ensuring a seamless experience from submission to final publication. I am truly honored to be featured in such a reputable platform and look forward to future collaborations."

img

Safana Abdullah Algutaini

Testimonial for the Journal of Biomedical Research and Clinical Advancements It was a truly rewarding experience publishing our study, "Single-Surgeon Outcomes of Left Ventricular Aneurysm Repair in Wartime Syria: A 10-Year Retrospective Study at Damascus University Cardiac Surgery Hospital," with the Journal of Biomedical Research and Clinical Advancements. The editorial and peer-review process was both rigorous and efficient, demonstrating a high standard of academic integrity and scientific scrutiny. The journal’s commitment to open access and global health equity is evident in its support of research emerging from conflict-affected and resource-limited settings—making our work not only visible but impactful. The professionalism of the editorial team, the speed of communication, and the clarity of submission guidelines all contributed to a smooth publication process. We were particularly impressed by the quality of the publication layout and the prompt indexing of our article, which enhances its accessibility to clinicians, researchers, and policymakers worldwide. We are proud to have contributed to this journal and highly recommend it to fellow researchers seeking a reputable platform to disseminate clinically significant and globally relevant findings.